Navigation Links
Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
Date:5/7/2008

Panel on Hemoglobin-Based Oxygen Carriers Indicates Support for Continued

Investigational Use Where Blood Is Not an Option

CAMBRIDGE, Mass., May 7 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that the Company's strategy to pursue indications for its product Hemopure(R) [hemoglobin glutamer-250 (bovine)] , or HBOC-201, when blood is not an option was reinforced by the National Institutes of Health/Food and Drug Administration (NIH/FDA) recent workshop. The workshop, entitled "The Safety of Hemoglobin-based Oxygen Carriers," took place on April 29 and 30, 2008 in Bethesda, Maryland. The purpose of a public workshop is to discuss issues in featured presentations and roundtable discussions led by experts from academic institutions, government, and industry. No actions are typically taken at workshops. The transcript is expected to be available on the FDA website by late May 2008.

"A number of participants in this important workshop recognize the therapeutic potential that Hemoglobin-based Oxygen Carriers (HBOCs) offer to patients who may not have the option of receiving packed red blood cells," said Biopure Chairman and CEO Zafiris G. Zafirelis. "The company's initial strategy with Hemopure was to develop indications in the treatment of adult surgical patients who are acutely anemic, as in South Africa, where Hemopure has market authorization and is being used clinically. We also believe there are excellent applications for its use where blood is not indicated, and in out-of-hospital treatment of trauma patients in hemorrhagic shock, where red blood cells are not available."

Biopure Vice President of Medical Affairs Dr. A. Gerson Greenburg delivered the company's presentation,
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Biopure Announces Reverse Stock Split
2. Biopures Stock Symbol Reverts to BPUR
3. Biopure Announces Closing of $14.9 Million Financing
4. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
5. Biopure Announces 2007 Fourth Quarter and Year-End Financial Results
6. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
7. New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
8. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
9. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
10. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
11. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Computer Resources of America, Inc. ... New York City, has been awarded the contract to ... of a large global bank. The bank is a ... Ramnarayan, CEO of CRA said, “Being awarded this contract ... further develop what has already been a successful and ...
(Date:7/30/2014)... July 30, 2014 According to the Critical ... is a comprehensive bodybuilding guide for men who want to ... up to 50 pounds in within a few months. Inside ... help keep their shoulders healthy and avoid the aches and ... Bench Program 2.0 uncovers to learners the reason why stretching ...
(Date:7/30/2014)... pMD, the leading innovator in ... Observation Result (ORU) interface to streamline cardiology test ... are using the ORU interface to automate charge ... for electrocardiograms, echocardiograms, and stress tests. , When ... cardiology system produces electronic data for each test ...
(Date:7/29/2014)... (PRWEB) July 30, 2014 VisitandCare.com ... centers have been added to the company’s exclusive network ... develop out of joint efforts — as top fertility ... initiative to offer affordable, state-of-the-art, and successful IVF treatments. ... begins with a comprehensive study by professionals at VisitandCare.com. ...
(Date:7/29/2014)... St. Petersburg, FL (PRWEB) July 30, 2014 Phytceramides ... explains how and why in her new book. , Today is ... Phytoceramides: Anti Aging At Its Best . The book is ... larger skin care book, but felt that Phytoceramides were ... sense to bring out this focused book now," says Kathy Heshelow, ...
Breaking Medicine News(10 mins):Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 2Health News:The Critical Bench Program 2.0 Pdf Review Exposes Mike Westerdal's Guide for Increasing Bench Press – Vkool.com 3Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 2Health News:pMD Automates Cardiology Charge Capture: Low-Reimbursement Services Become Profitable 3Health News:Top European Fertility Clinics Join VisitandCare.com 2Health News:Top European Fertility Clinics Join VisitandCare.com 3Health News:Top European Fertility Clinics Join VisitandCare.com 4Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 2Health News:Last Day New Book Is Available at No Cost: Phytoceramides, Anti Aging At Its Best by Sublime Beauty Founder® Kathy Heshelow 3
... drug-free way to treat agitation and depression among dementia patients, ... to know for sure, according to a review of recent ... during conversation helped ease agitation and restore appetite in dementia ... ,“Although the available reliable evidence supports the use of massage ...
... lead to the growth and spread of cancer. Controlling stress ... that stress results in the release of hormones that aggravate ... stimulates cancer cells to produce two compounds that can breakdown ... move easily into the bloodstream and travel to other parts ...
... a dramatic increase in the number of statin prescriptions in ... organised by the Royal College of Physicians of Edinburgh//. ... to offer a prescription than to persuade people to make ... a relatively low risk of heart disease were being put ...
... who inevitably convey the poisonous toxic meth chemicals to their ... novel Canadian Study. , ,Motherisk lab at the Hospital ... hair samples of adults and young children to gauge their ... is conveyed from the expectant mother to the unborn child. ...
... umbilical cord blood stem cells for the first time by ... drug testing. ,According to the scientists, this mini ... initial phase of generating segments that can be made use ... form. ,Scientists from Newcastle University worked in ...
... towards making healthcare more affordable, over 880 medicines including ... well as antibiotics would become cheaper. ,The new ... from Thursday with the government fixing the wholesale and ... of Chemicals and Fertiliser Ram Vilas Paswan said Tuesday ...
Cached Medicine News:Health News:Massage May Help Dementia Patients With Agitation 2Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Increased Warning over heart drugs 2Health News:Artificial Liver from Cord Blood Stem cells 2
(Date:7/30/2014)... July 30, 2014 /PRNewswire-iReach/ -- This is a ... Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS ... information of Heparin sodium (CAS 9041-08-1) & calcium ... technology. The report then explores global and China,s ... calcium (CAS 37270-89-6) listing their product specification, capacity, ...
(Date:7/30/2014)... -- Hospira, Inc. (NYSE: HSP ), the ... technologies, today reported results for the second quarter ... quarter were $1.1 billion and adjusted* diluted earnings ... items as described later in this press release ... Accepted Accounting Principles (GAAP) basis, second-quarter 2014 diluted ...
(Date:7/30/2014)... , July 30, 2014   Medical Equipment Solutions, ... been awarded a Department of Defense (US Army) contract ... supply a mobile MRI diagnostic machine and technical support ... (WOSB) through the Small Business Administration (SBA), Medical Equipment ... field with the latest medical diagnostic equipment. The SBA ...
Breaking Medicine Technology:Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... 24, 2012 Marking a major milestone for ... a developer of oral drug delivery systems, announced today that ... Australian Patent Office. The patent covers an important part of ... of peptides. Oramed,s portfolio now consists of one issued patent ...
... Jan. 24, 2012  LoneStar Heart Inc., based here, today ... and Mark Maciejewski to the company,s board of directors. ... the board for LoneStar Heart; Frank Ahmann, the company,s ... executive officer of Vessix Vascular, Inc.; and Eric N. ...
Cached Medicine Technology:Oramed Pharmaceuticals Granted Australian Patent for Important Part of the Company's Core Technology in Oral Delivery of Proteins 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 2LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors 3
Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....
Smooth pointed tips open to 3.0 mm. Straight shafts. Cross action. Round handle....
Flat handle 9 mm wide, angulated 45....
Straight tips with delicate serrations. Serrated handle with polished finish....
Medicine Products: